Acta Pharmaceutica Sinica B
Displaying 1 - 2 of 2
Feng, Y., Chen, C., Shao, A., Wu, L., Hu, H., & Zhang, T. (2024). Emerging interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitors or degraders as therapeutic agents for autoimmune diseases and cancer. Acta Pharmaceutica Sinica B, 14(12), 5091–5105. https://doi.org/10.1016/j.apsb.2024.09.008
Publication Date
Columbia Affiliation
Zahr, T., Boda, V. K., Ge, J., Yu, L., Wu, Z., Que, J., Li, W., & Qiang, L. (2024). Small molecule conjugates with selective estrogen receptor β agonism promote anti-aging benefits in metabolism and skin recovery. Acta Pharmaceutica Sinica B, 14(5), 2137–2152. https://doi.org/10.1016/j.apsb.2024.01.014
Publication Date
Columbia Affiliation
Vagelos College of Physicians and Surgeons; Department of Pediatrics; Division of Pediatric Gastroenterology, Hepatology, and Nutrition; Department of Medicine; Division of Preventive Medicine and Nutrition; Division of Digestive and Liver Diseases; Naomi Berrie Diabetes Center; Department of Molecular Pharmacology and Therapeutics; Center for Human Development; Department of Pathology and Cell Biology